Interview | Prof. Dr. Petra Ritter, Head of TEF-Health and Dr. Dirk Schlesinger, Head of TÜV AI Lab

“Ultimately, the goal is to bring health-innovations Made in Europe to the marketplace.”

6 Min
More

DX Technology Demonstrates High Detection Accuracy for Atrial Fibrillation in Single-Chamber ICD Patients

Large-scale study shows that DX-ICD systems together with Home Monitoring allow for reliable guideline-recommended monitoring of subclinical AF

3 Min
More

Max Delbrück Center discovers how non-coding parts of the genome drive evolution

Genes are not the only drivers of evolution. The iconic fins of skates are caused by changes in the non-coding parts of the genome and its three-dimensional structure, a research team including Darío Lupiáñez at the Max Delbrück Center reports in…

4 Min
More

Eckert & Ziegler Receives Environmental Approval for Jintan Radioisotope Site

 

Berlin, 12 April 2023 – Eckert & Ziegler’s fully owned subsidiary Qi Kang Medical Technology Ltd. (QKM) has recently received the authorization for its Environmental Impact Assessment (EIA) from the Department of Ecology and Environment of Jiangsu…

1 Min
More

Eckert & Ziegler to Supply POINT Biopharma with Actinium-225

 

Berlin, Germany and Indianapolis, Indiana, USA – 4 April 2023 – Eckert & Ziegler (ISIN DE0005659700, TecDAX) and a subsidiary of POINT Biopharma Global Inc. (“POINT”, NASDAQ: PNT) have signed an agreement on the supply of Actinium-225…

3 Min
More

Scientists from the Berlin Institut of Health have discovered that autoantibodies in Covid-19 patients are likely not to blame when patients become severely ill

Critically ill COVID-19 patients often have antibodies in their blood that bind to the body’s own structures, so-called autoantibodies. Scientists from the BIH at Charité and the Max Delbrück Center have now discovered that these autoantibodies…

3 Min
More

Nasal vaccine, developed by researchers from Berlin, to prevent COVID-19 passes first tests

Since the beginning of the COVID-19 pandemic, researchers have been working on mucosal vaccines that can be administered through the nose. Now, scientists in Berlin, including researchers from Charité – Universitätsmedizin Berlin, have developed and…

6 Min
More

Speed Lecture Award 2023 finals on May 16th in Berlin: our shortlist candidates

We proudly announce the Speed Lecture Award finalists in 2023 that had been selected by the jury. Congratulations to all of them and good luck for your final performance on May 16th at Ludwig Erhard Haus in Berlin!

2 Min
More

Using bone marrow stromal cells instead of transplantation

Bone is the second most commonly transplanted tissue after blood, with about two million bone transplants performed worldwide each year – but often with only moderate therapeutic success. Cell-based therapies could provide an alternative approach to…

3 Min
More

Supporting innovation in biomedicine

The Max Delbrück Center wants to shape the future of medicine through innovation. But turning basic research into marketable products requires gaps to be bridged. This is achieved by the Technology Transfer Office – through funding schemes such as…

7 Min
More
Show more items